Vanda Pharmaceuticals
VNDA
VNDA
163 hedge funds and large institutions have $524M invested in Vanda Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 55 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
1.61% less ownership
Funds ownership: 101.1% → 99.48% (-1.6%)
17% less capital invested
Capital invested by funds: $631M → $524M (-$107M)
60% less call options, than puts
Call options by funds: $1.08M | Put options by funds: $2.69M
Holders
163
Holding in Top 10
1
Calls
$1.08M
Puts
$2.69M
Top Buyers
| 1 | +$6.28M | |
| 2 | +$4.33M | |
| 3 | +$2.76M | |
| 4 |
Goldman Sachs
New York
|
+$2.68M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
+$2M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$3.6M | |
| 3 | -$3.42M | |
| 4 |
Prudential Financial
Newark,
New Jersey
|
-$3.04M |
| 5 |
WG
Winton Group
London,
United Kingdom
|
-$2.98M |